Delivery Order SPE2DB20D3505-SPE2DB23FT6Y6
Award Date
2/9/23
Potential Completion Date
2/10/23
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides Mesalamine delayed-release 1.2 gram tablets for a ceiling value of $10,635.52. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,170.87, is for the delivery of 4,563,198,346 units of Mesalamine 800 mg delayed-release tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,141.61, is for the delivery of Mesalamine 800 mg delayed-release tablets. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves...
This federal contract award is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,552.99 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of February 26, 2025. This award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.43 firm fixed-price delivery order is for the supply of 4,561,731,416 units of Mesalamine DR 1.2 GM Tablets in quantities of 120 per bottle. The contract has an ultimate completion date of August 8, 2023 and was awarded on August 7, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award is for the delivery of Mesalamine 800 mg delayed-release tablets to the Defense Logistics Agency (DLA), a defense agency. The $2,026.42 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 29, 2024. The contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Mesalamine 800 mg delayed-release tablets. The $13,126.28 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a period of performance through September 16, 2024 and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) vehicle the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mesalamine 800 mg delayed-release (DR) tablets. The contract has a ceiling value of $9,424.34 and an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). This contract...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUYE2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,943,595 tablets of the medication Mesalamine DR 1.2 GM. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,247.15 and an ultimate completion date of April 17, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,258.34, is for the delivery of Mesalamine delayed-release tablets to support federal healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...